Table 4.
SUVR-Centiloid | |||||
HC (n = 70) | MCI/AD (n = 32) | ||||
mg/dl | ρ | p | ρ | p | |
HDL | 0.010 | 0.931 | –0.325 | 0.070 | |
HDL L | 0.083 | 0.493 | –0.371 | 0.037 | |
HDL I | –0.054 | 0.660 | –0.160 | 0.382 | |
HDL S | 0.008 | 0.950 | 0.225 | 0.216 | |
Plasma Aβ1–42 (pg/ml) | |||||
HC (n = 346) | MCI/AD (n = 135) | ||||
mg/dl | ρ | p | ρ | P | |
HDL | 0.013 | 0.815 | 0.118 | 0.174 | |
HDL L | 0.015 | 0.774 | 0.089 | 0.304 | |
HDL I | –0.025 | 0.637 | 0.080 | 0.357 | |
HDL S | 0.041 | 0.443 | 0.088 | 0.310 |
Spearman’s correlation evaluating brain amyloidosis or plasma Aβ1–42 levels with HDL (or HDL subgroups) was performed in HC, MCI, and AD and considered significant when p < 0.05 (bold).